# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001600620-24-000083
Filing Date
2024-06-04
Accepted
2024-06-03 18:28:37
Documents
20

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | combined2024defa14a_agmxci.htm | DEFA14A | 86861
2 |  | auph_-x2024agmcircularsu001.jpg | GRAPHIC | 250007
3 |  | auph_-x2024agmcircularsu002.jpg | GRAPHIC | 79954
4 |  | auph_-x2024agmcircularsu003.jpg | GRAPHIC | 203671
5 |  | auph_-x2024agmcircularsu004.jpg | GRAPHIC | 235563
6 |  | auph_-x2024agmcircularsu005.jpg | GRAPHIC | 228645
7 |  | auph_-x2024agmcircularsu006.jpg | GRAPHIC | 225885
8 |  | auph_-x2024agmcircularsu007.jpg | GRAPHIC | 182873
9 |  | auph_-x2024agmcircularsu008.jpg | GRAPHIC | 205672
10 |  | auph_-x2024agmcircularsu009.jpg | GRAPHIC | 236065
11 |  | auph_-x2024agmcircularsu010.jpg | GRAPHIC | 267226
12 |  | auph_-x2024agmcircularsu011.jpg | GRAPHIC | 248613
13 |  | auph_-x2024agmcircularsu012.jpg | GRAPHIC | 274716
14 |  | auph_-x2024agmcircularsu013.jpg | GRAPHIC | 271672
15 |  | auph_-x2024agmcircularsu014.jpg | GRAPHIC | 249640
16 |  | auph_-x2024agmcircularsu015.jpg | GRAPHIC | 215019
17 |  | auph_-x2024agmcircularsu016.jpg | GRAPHIC | 249848
18 |  | auph_-x2024agmcircularsu017.jpg | GRAPHIC | 189035
19 |  | auph_-x2024agmcircularsu018.jpg | GRAPHIC | 227234
20 |  | auph_-x2024agmcircularsu019.jpg | GRAPHIC | 91682
| Complete submission text file | 0001600620-24-000083.txt |  | 5782046

Mailing Address #140, 14315 - 118 AVENUE EDMONTON A0 T5L 4S6
Business Address #140, 14315 - 118 AVENUE EDMONTON A0 T5L 4S6 250-744-2487
Aurinia Pharmaceuticals Inc. (Filer) CIK: 0001600620 (see all company filings)

EIN.: 981231763 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36421 | Film No.: 241015412
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)